메뉴 건너뛰기
Gut
Volumn 64, Issue 6, 2015, Pages 1005-1006
Discontinuation of long-term NA therapy in HBeAg-negative chronic hepatitis B
Author keywords

[No Author keywords available]
Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; NUCLEOSIDE ANALOG; ANTIVIRUS AGENT; GUANINE;
EID: 84935014349     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308677     Document Type: Note
Times cited : (13)
References (5)
  • 1
    • 84923060517 scopus 로고    scopus 로고
    • Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: A multicentre prospective study
    • Seto WK, Hui AJ, Wong V.W., et al. Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study. Gut 2015; 64:667-72.
    • (2015) Gut , vol.64 , pp. 667-672
    • Seto, W.K.1    Hui, A.J.2    Wong, V.W.3
  • 2
    • 84888287261 scopus 로고    scopus 로고
    • Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
    • Jeng WJ, Sheen IS, Chen Y.C., et al. Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients. Hepatology 2013; 58:1888-96.
    • (2013) Hepatology , vol.58 , pp. 1888-1896
    • Jeng, W.J.1    Sheen, I.S.2    Chen, Y.C.3
  • 3
    • 84918522516 scopus 로고    scopus 로고
    • Can nucleos(t)ide analogue (NA) therapy ever be stopped in HBeAg-negative chronic hepatitis B?
    • Hadziyannis SJ, Vassilopoulos D, Sevastianos V., et al. Can Nucleos(t)ide Analogue (NA) Therapy Ever be Stopped in HBeAg-Negative Chronic Hepatitis B? Curr Hepatol Rep 2014; 13:256-63.
    • (2014) Curr Hepatol Rep , vol.13 , pp. 256-263
    • Hadziyannis, S.J.1    Vassilopoulos, D.2    Sevastianos, V.3
  • 4
    • 84865487986 scopus 로고    scopus 로고
    • Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir
    • Hadziyannis SJ, Sevastianos V, Rapti I., et al. Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir. Gastroenterology 2012; 143: 629-36.
    • (2012) Gastroenterology , vol.143 , pp. 629-636
    • Hadziyannis, S.J.1    Sevastianos, V.2    Rapti, I.3
  • 5
    • 77955494346 scopus 로고    scopus 로고
    • Use of hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers
    • Brunetto MR, Oliveri F, Colombatto P., et al. Use of hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 2010; 139:483-90.
    • (2010) Gastroenterology , vol.139 , pp. 483-490
    • Brunetto, M.R.1    Oliveri, F.2    Colombatto, P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.